Ledger.Open graph →
SEC Form D · filed July 22, 2020

Magnolia Neurosciences Corp

Offering
$17.9M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Kendall Mohler · New York, NYExecIan Howes · New York, NYExecThong Le · New York, NYExec · DirectorAlice J. Ly · New York, NYDirectorSteve Gillis · New York, NYDirectorMichael J. Baran · New York, NYDirectorM. J. Erwin · New York, NYDirectorMargarita J. Chavez · New York, NYDirectorDavid Schubert · Seattle, WAExecAsish Xavier · San Francisco, CADirectorBenjamin I. Samaroo · Vancouver, British Columbia, CanadaDirectorDean I. Sutton · Vancouver, British Columbia, CanadaExec · DirectorTodd W. Kibler · Milwaukee, WIExecAdele Gorrilla · Philadelphia, PAExecSheona I. Docksteader · Vancouver, British Columbia, CanadaDirectorSteven I. Krause · Vancouver, British Columbia, CanadaExecJohn Mcmahon · SAN FRANCISCO, CADirectorJon D. Hammes · Milwaukee, WIDirectorAlfred Vericel · Paris, I0DirectorBill I. Koutsouras · Vancouver, British Columbia, CanadaDirectorRoger Mills · Geneva, V8ExecMikhail Kalinichev · Geneva, V8Exec · DirectorJake Nunn · Menlo Park, CADirectorJean-Philippe Rocher · Geneva, V8DirectorTimothy Dyer · Geneva, V8DirectorIsaac Manke · New York, NYExecVincent Lawton · Geneva, V8DirectorAri Qayumi · Menlo Park, CAExecJosephine B. Andonissamy · Luxembourg, LuxembourgDirectorMartin Dolfi · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗